Ben Gust - Profile and Investment Details

Investor Profile

Ben Gust is a Micro VC based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as Peplin, Phenomix, Nuon Therapeutics, Moximed, Xenome, Elastagen, Spinifex Pharmaceuticals, Verva Pharmaceuticals, Hatchtech, CHF Solutions, Ocunexus Therapeutics, Humanigen, OPAL Therapeutics, AIMEDICS, Hydrexia, Applied Physiology, Viveve, Pathway Therapeutics, Neurovance, Celladon, NovaSys, Uptake Medical, AirXpanders, ChemGenex Pharmaceuticals, NeuroVista, NOVASYS MEDICAL, Ivantis, Proacta, Euthymics Bioscience. Over time, Ben Gust has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ben Gust is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Medical Device, Healthcare, Biotechnology, Neuroscience, Clinical Trials, Health Diagnostics, Medical, Pharmaceuticals may find it worthwhile to explore potential connections with Ben Gust, as their portfolio suggests a familiarity and interest in this area.

Understanding Ben Gust’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.